Viracta

is a California-based biotechnology company that researches and develops novel therapeutics to treat cancer and virus-affected diseases...
Read more
Viracta President & CEO: Mark Rothera

President & CEO

Mark Rothera

CEO Approval Rating

90/100

Annual Revenue
<$1M
Employees
20
Funding
$206.7M

Viracta Competitors

1Atara
2Tessa
3AlloVir
4Kite Pharma
5bluebird bio
6Inovio
7VBI
8Agenus
9Dynavax
10Immune Design

Trending Companies